These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11808348)

  • 1. [Adult form of acid maltase deficiency presenting with pattern of muscle weakness resembling facioscapulohumeral dystrophy].
    Oya Y; Morita H; Ogawa M; Nonaka I; Tsujino S; Kawai M
    Rinsho Shinkeigaku; 2001 Jul; 41(7):390-6. PubMed ID: 11808348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A 21-year-old man with distal dominant progressive muscle atrophy].
    Hattori Y; Nohara C; Hirasawa E; Mori H; Imai H; Mizuno Y
    No To Shinkei; 1995 May; 47(5):509-18. PubMed ID: 7786629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facioscapulohumeral muscular dystrophy with severe mental retardation and epilepsy.
    Saito Y; Miyashita S; Yokoyama A; Komaki H; Seki A; Maegaki Y; Ohno K
    Brain Dev; 2007 May; 29(4):231-3. PubMed ID: 17010549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facioscapulohumeral dystrophy presenting as infantile facial diplegia and late-onset limb-girdle myopathy in members of the same family.
    Felice KJ; Jones JM; Conway SR
    Muscle Nerve; 2005 Sep; 32(3):368-72. PubMed ID: 15880682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Becker's muscular dystrophy aggravating facioscapulohumeral muscular dystrophy--double trouble as an explanation for an atypical phenotype.
    Rudnik-Schöneborn S; Weis J; Kress W; Häusler M; Zerres K
    Neuromuscul Disord; 2008 Nov; 18(11):881-5. PubMed ID: 18684626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permanent muscle weakness in McArdle disease.
    Nadaj-Pakleza AA; Vincitorio CM; Laforêt P; Eymard B; Dion E; Teijeira S; Vietez I; Jeanpierre M; Navarro C; Stojkovic T
    Muscle Nerve; 2009 Sep; 40(3):350-7. PubMed ID: 19670320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A patient with dermatomyositis and systemic sclerosis with preferential facioscapulohumeral muscle involvement and fatal cardiomyopathy].
    Oya Y; Toyama J; Ogawa M; Nonaka I; Kawai M
    Rinsho Shinkeigaku; 2001 Jun; 41(6):289-95. PubMed ID: 11771157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glycogen storage disease (Pompe's disease) presenting as myopathy in the adult (author's transl)].
    Stefan H; Böker DK; Müller J; Gullotta F
    Dtsch Med Wochenschr; 1977 Oct; 102(42):1512-4. PubMed ID: 269788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FSHD-like patients without 4q35 deletion.
    Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
    J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beevor's sign in facioscapulohumeral muscular dystrophy: an old sign with new implications.
    Eger K; Jordan B; Habermann S; Zierz S
    J Neurol; 2010 Mar; 257(3):436-8. PubMed ID: 19838767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abnormal head drooping in facioscapulohumeral muscular dystrophy].
    Ichikawa Y; Yamada H; Motoyoshi Y; Shimizu T; Kawai M
    Rinsho Shinkeigaku; 1996 Mar; 36(3):503-6. PubMed ID: 8741360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
    Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
    Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymptomatic elevation of serum creatine kinase leading to the diagnosis of 4q35 facioscapulohumeral muscular dystrophy.
    Zouvelou V; Manta P; Kalfakis N; Evdokimidis I; Vassilopoulos D
    J Clin Neurosci; 2009 Sep; 16(9):1218-9. PubMed ID: 19502063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.
    Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E
    Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first Italian patient with oculopharyngodistal myopathy: case report and considerations on differential diagnosis.
    Mignarri A; Carluccio MA; Malandrini A; Sicurelli F; Galli L; Mazzei MA; Federico A; Orrico A; Dotti MT
    Neuromuscul Disord; 2012 Aug; 22(8):759-62. PubMed ID: 22652077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic challenges in facioscapulohumeral muscular dystrophy.
    Sacconi S; Salviati L; Bourget I; Figarella D; Péréon Y; Lemmers R; van der Maarel S; Desnuelle C
    Neurology; 2006 Oct; 67(8):1464-6. PubMed ID: 17060574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile onset acid maltase deficiency presenting as a rigid spine syndrome.
    Kostera-Pruszczyk A; Opuchlik A; Lugowska A; Nadaj A; Bojakowski J; Tylki-Szymanska A; Kaminska A
    Neuromuscul Disord; 2006 Apr; 16(4):282-5. PubMed ID: 16531044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic involvement in a case of lysosomal glycogen storage disease with normal acid maltase].
    Matsumoto S; Yamada T; Tanaka K; Hara H; Nonaka I; Uchida T; Miyagi Y; Fukutomi T; Kira J
    Rinsho Shinkeigaku; 1999 Jul; 39(7):717-21. PubMed ID: 10548908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.
    Fatehi F; Salort-Campana E; Le Troter A; Bendahan D; Attarian S
    Rev Neurol (Paris); 2016 Oct; 172(10):566-571. PubMed ID: 27663058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prosthetic treatment of a patient with facioscapulohumeral muscular dystrophy: a clinical report.
    Güler AU; Ceylan G; Ozkoç O; Aydiin M; Cengiz N
    J Prosthet Dent; 2003 Oct; 90(4):321-4. PubMed ID: 14564285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.